← Back
$VRTX All transactions

VERTEX PHARMACEUTICALS INC / MA

▼ SELL 10b5-1 Plan

$ Value

$281K

Shares

694

Price

$404

Filed

Oct 3

Insider

Name

Biller Jonathan

Title

EVP and Chief Legal Officer

CIK

0001744749

Roles

Officer

Transaction Details

Transaction Date

2025-10-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

15,653

Footnotes

Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/24/2025.

Filing Info

Accession No.

0000875320-25-000224

Form Type

4

Issuer CIK

0000875320

Biller Jonathan's History

Date Ticker Type Value
2026-02-11 VRTX $886K
2026-02-10 VRTX F $764K
2026-01-22 VRTX A $0
2026-01-22 VRTX A $0
2025-12-03 VRTX $156K
2025-10-02 VRTX $281K
2025-10-01 VRTX F $504K

Other Insiders at VRTX (90d)

Insider Bought Sold Last
SACHS BRUCE I 2026-04-15
WAGNER CHARLES F JR
EVP, CO & FO
2026-01-22
LEIDEN JEFFREY M
Executive Chairman
2026-01-22
Garber Alan M 2026-04-15
Sachdev Amit
EVP Chief Patient & Ext Af Off
2026-01-22
Upadhyay Suketu 2026-04-15
ALTSHULER DAVID
EVP, Chief Scientific Officer
2026-01-22
Kewalramani Reshma
CEO & President
2026-01-22
Biller Jonathan
EVP and Chief Legal Officer
$886K 2026-02-11
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
2026-01-22
Bozic Carmen
EVP and CMO
$1.1M 2026-03-27
Liu Joy
EVP and Chief Legal Officer
$439K 2026-04-01
Ambrose Kristen
SVP & Chief Accounting Officer
$634K 2026-02-11
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
$806K 2026-02-11
McKechnie Duncan
EVP, Chief Commercial Officer
2026-01-22
Bunnage Mark E.
EVP, Chief Scientific Officer
$931K 2026-02-11